ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE

Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY

Bristol-myers Squibb Company BMY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Bristol-myers Squibb Company BMY

FDA approves Bristol Myers Squibb's CAR-T therapy
Shares of Bristol Myers Squibb Co. were down 0.8% in trading on Monday, following the announcement on Friday that the Food and Drug Administration approved Breyanzi, its large B-cell lymphoma treatment. The wholesale list price is 0,300 for the total c
Announcement as on 08 February 2021

Bristol Myers posts billion loss as it books charges relating to MyoKardia and Celgene
Bristol Myers Squibb Co. said Thursday it had a net loss of .027 billion, or .45 a share, in the fourth quarter, wider than the loss of .056 billion, or 55 cents a share, posted in the year-earlier period, weighed down by charges relating to the My
Announcement as on 04 February 2021

Bristol Myers adds billion to share buyback program
Bristol Myers Squibb Co. said Monday its board has approved an additional billion of share buybacks, bringing the company's full authorization to about .4 billion. Shares rose 1% premarket, but have fallen 3% in the last 12 months, while the S&P 500
Announcement as on 11 January 2021

Bristol Myers Squibb's Opdivo failed a study testing it as a treatment for rare cancer
Shares of Bristol Myers Squibb were down 0.1% in premarket trading on Wednesday after the company said its cancer drug Opdivo failed a Phase 3 clinical trial for patients with a type of newly diagnosed glioblastoma. An independent data monitoring committe
Announcement as on 23 December 2020

Cipla rallies 5% after settling litigation with Bristol Myers in US
Bristol Myers (Celgene) will provide Cipla with a license to sell generic volume-limited amounts of gRevlimid capsules in the US sometime after March 2022, subject to regulatory approval
Announcement as on 14 December 2020

Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |

BMY Bristol-myers Squibb Company current price & indicator signals

Moving Averages for Bristol-myers Squibb Company

  • 5Day Average: 58.64
  • 12Day Average: 59.07
  • 20Day Average: 58.9
  • 50Day Average: 59.88
  • 100Day Average: 56.67
  • 150Day Average: 52.88
  • 200Day Average: 51.44

BMY Indicators & signals

Indicator MACD (12,26,9)

58.99, 59.12, -0.17
Indicator MACD is in negative zone

Indicator ADX (14)

14.71, 27.27, 20.28
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Fri Apr 2026 60.17 58.54 to 60.48 2.05% 1.52 times
16 Thu Apr 2026 58.96 57.66 to 58.98 1.85% 0.54 times
15 Wed Apr 2026 57.89 57.22 to 58.16 -0.36% 1.15 times
14 Tue Apr 2026 58.10 57.56 to 58.62 0.07% 0.49 times
13 Mon Apr 2026 58.06 57.55 to 58.90 -0.96% 1.39 times
10 Fri Apr 2026 58.62 58.46 to 59.80 -1.43% 0.66 times
09 Thu Apr 2026 59.47 58.54 to 59.69 0.46% 0.87 times
08 Wed Apr 2026 59.20 57.67 to 59.23 2.65% 1.53 times
07 Tue Apr 2026 57.67 57.65 to 59.23 -2.8% 1.19 times
06 Mon Apr 2026 59.33 58.77 to 59.63 -0.44% 1.05 times
02 Thu Apr 2026 59.59 59.10 to 61.00 -3.51% 1.14 times
01 Wed Apr 2026 61.76 60.61 to 62.23 1.83% 0.76 times

Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE

 

Back to top